Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALL

NCT01148134 · clinicaltrials.gov ↗
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class

Stopped Analysis of the first 10 patients did not show anyt trend toward differences in PK profiles between imatinib vs no imatinib groups.

Conditions

Sponsor

University Health Network, Toronto